Azitra (AZTR) Revenue (2022 - 2024)
Azitra (AZTR) posted Revenue of $7500.0 for Q2 2024, down 91.67% on a QoQ basis from $90000.0 in Q4 2023, and down 95.64% year-over-year from $172000.0 in Q3 2023.
Azitra (AZTR) Revenue (2022 - 2024) Analysis & Trends
Azitra's Revenue history runs 3 years deep, the most recent figure standing at $7500.0 for Q2 2024.
- Quarterly Revenue fell 95.64% year-over-year to $7500.0 in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $7500.0 (down 98.16% YoY) and the FY2024 annual result came in at $7500.0, down 98.91% from the prior year.
- Revenue was $7500.0 for Q2 2024 at Azitra, down from $90000.0 in the prior quarter.
- Across five years, Revenue topped out at $310700.0 in Q3 2023 and bottomed at $7500.0 in Q2 2024.
- A 3-year average of $107187.5 and a median of $87500.0 in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue surged 540.62% — and 2024, when it sank 95.64%.
- Azitra's Revenue stood at $30500.0 in 2022, then surged by 195.08% to $90000.0 in 2023, then tumbled by 91.67% to $7500.0 in 2024.
- Business Quant data shows AZTR's Revenue at $7500.0 in Q2 2024, $90000.0 in Q4 2023, and $310700.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,780.80 Bn | 1,780.74 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 472.52 Bn | 467.73 Bn | 1.35 Bn | 1.51 Bn |
| 4 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 2.99 Bn |
| 5 | Regeneron Pharmaceuticals | 71.56 Bn | 62.81 Bn | 3.31 Bn | 3.61 Bn |
| 6 | Belite Bio | 62.37 Bn | 62.37 Bn | - | - |
| 7 | Argenx Se | 54.58 Bn | 49.39 Bn | 1.41 Bn | 1.56 Bn |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn | 1.17 Bn |
| 9 | Revolution Medicines | 36.40 Bn | 36.40 Bn | - | - |
| 10 | Azitra | 2.02 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 7,500.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 310,700.00 |
| Jun 30, 2023 | 172,000.00 |
| Mar 31, 2023 | 113,300.00 |
| Dec 31, 2022 | 30,500.00 |
| Sep 30, 2022 | 48,500.00 |
| Jun 30, 2022 | 85,000.00 |